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 Abstract 
 
This paper presents an overview of the 
MammoGrid project and some of its achievements.  
In terms of the global grid project, and European 
research in particular, the project has successfully 
demonstrated the capacity of a grid-based system to 
support effective collaboration between physicians, 
including handling and querying image databases, as 
well as using grid services, such as image 
standardization and Computer-Aided Detection 
(CADe) of suspect or indicative features.  In terms of 
scientific results, in radiology, there have been 
significant epidemiological findings in the assessment 
of breast density as a risk factor, but the results for 
CADe are less clear-cut.  Finally, the foundations of 
a technology transfer process to establish a working 
“MammoGrid plus” system in Spain through the 
company Maat GKnowledge and the collaboration of 
CIEMAT and hospitals in Extremadura. 
 
1. Background   
 
 Breast cancer is arguably the most pressing 
threat to women’s health.  For example, in the UK, 
more than one in four female cancers occur in the 
breast and these account for 18% of deaths from 
cancer in women.  Coupled with the statistic that 
about one in four deaths in general are due to cancer, 
this suggests that nearly 5% of female deaths are due 
to breast cancer.  While risk of breast cancer to age 
50 is 1 in 50, risk to age 70 increases to 1 in 15 and 
lifetime risk has been calculated as 1 in 9.  The 
problem of breast cancer is best illustrated through 
comparison with lung cancer which also accounted 
for 18% of female cancer deaths in 1999.  In recent 
years, almost three times as many women have been 
diagnosed with breast cancer as with lung cancer.  
However, the five year survival rate from lung cancer 
stands at 5%, while the breast cancer figure is 73%.  
This is testament to the effectiveness of modern 
treatments, provided breast cancer is diagnosed 
sufficiently early.  These statistics are echoed in other 
countries.  The lifetime risk of breast cancer in the 
USA has been estimated as 1 in 8.  Here also 
incidence has increased but mortality decreased in the 
past twenty years.  There is evidence that stress and 
diet may also be correlated with breast cancer, 
although the underlying biochemistry is not fully 
understood.  For example, twenty years ago breast 
cancer was almost unknown in Japan but its incidence 
now approaches Western levels. (For a world-wide 
picture, see [1].) This may be associated with major 
changes that have occurred in Japan in this period, 
e.g. the increased consumption of high lipid foods 
and higher levels of stress with more women working.  
Finally, we note that a small number of men, e.g., 
about 100 in the UK and 400 in the US, also die 
annually of breast cancer. 
The statistics of breast cancer diagnosis and 
survival appear to be a powerful argument in favour 
of a universal screening programme.  However, a 
number of issues of efficacy and cost effectiveness 
limit the scope of most screening programmes.  The 
method of choice in breast cancer screening is 
mammography (breast X-ray), although self-
examination and clinical palpation are also used; for 
precise location of lesions and ‘staging’ (establishing 
how advanced the disease is) ultrasound and MRI 
may be used.  A significant difficulty lies in the 
typical composition of the female breast, which 
changes dramatically over the lifetime of a woman, 
with the most drastic change taking place around the 
menopause.  In younger women, the breast consists of 
around 80% glandular tissue which is dense and 
largely X-ray opaque.  The remaining 20% is mainly 
fat.  In the years leading up to the menopause, this 
ratio is typically reversed.  Thus in women under 50, 
signs of malignancy are far more difficult to discern 
in mammograms than they are in post-menopausal 
women.  Consequently, most screening programmes, 
including the UK’s, only apply to women over 50. [2] 
Given the decision to institute a screening 
programme, apart from deciding the subject age-
group, another vital question is that of frequency of 
screening.  Based on contemporary thinking and 
practice elsewhere in Europe, the UK programme was 
set up to screen every three years; however, by the 
time this was inaugurated, further research in Sweden 
suggested that screening should take place more 
often.  Indeed, one of the problems the UK 
programme has faced has been the phenomenon of 
so-called ‘interval cancers’, cancers which develop 
substantially in the three-year interval between 
screens. 
A further question which received a conservative 
answer in the UK was how many images of each 
breast should be taken.  It is generally believed that 
two images of each breast are ideal: a cranio-caudal 
(CC) image, vertically downwards through the breast, 
and a medio-lateral oblique (MLO) image, at 45º 
from shoulder to opposite hip, taking in part of the 
pectoral muscle.  However, in view of the resources 
needed to take and interpret four images, it was 
decided that two CC images should suffice. 
The increasing use of electronic formats for 
radiological images, including mammography, 
together with the fast, secure transmission of images 
and patient data, potentially enables many hospitals 
and imaging centres throughout Europe to be linked 
together to form a single grid-based “virtual 
organization”.  It is not yet precisely understood what 
advantages might accrue to radiologists working in 
such virtual organizations, as the technological 
possibilities are co-evolving with an appreciation of 
potential uses; but one that is generally agreed is the 
creation of huge “federated” databases of 
mammograms, which appear to the user to be a single 
database but are in fact retained and curated in the 
centres that generated them.  Each image in such a 
database would have linked to it a potentially large 
and expandable set of relevant information, known as 
metadata, about the woman whose mammogram it is.  
This might comprise: patient age, exogenous 
hormone exposure, family and clinical history; 
information known to correspond to risk factors (eg 
diet, parity, breast density); as well as image 
acquisition parameters, including breast compression 
and exposure data which affect image appearance.  
Levels of access to the images and metadata in the 
database would vary according to the “certificated 
rights” of the user: healthcare professionals might 
have access to essentially all of it, whereas 
epidemiologists, researchers, government officials 
would have more limited access, protecting patient 
privacy and in accordance with European legislation.   
 
The Fifth Framework EU-funded MammoGrid 
project [3] aimed to apply the grid concept to 
mammography, including services for the 
standardization of mammograms, computer-aided 
detection (CADe) of salient features, especially 
masses and ‘microcalcifications’, quality control of 
imaging, and epidemiological research including 
broader aspects of patient data.  In doing so, it 
attempted to create a paradigm for practical, grid-
based healthcare-oriented projects, particularly those 
which rely on imaging.  There are, however, a 
number of factors that make patient management 
based on medical images particularly challenging.  
Often very large quantities of data, with complex 
structures, are involved (such as 3-D images, time 
sequences, multiple imaging protocols etc.).  Also, 
clinicians rarely analyse single images in isolation but 
rather in a series or in the context of metadata.  
Metadata that may be required are clinically relevant 
factors such as patient age, exogenous hormone 
exposure, family and clinical history; for the 
population, natural anatomical and physiological 
variations; and for the technology, image acquisition 
parameters, including breast compression and 
exposure data. 
Thus any database of images developed at a 
single site may not contain enough exemplars in 
response to any given query to be statistically 
significant. Overcoming this problem implies 
constructing a very large, federated database, which 
can transcend national boundaries.  However this 
necessitates specialist image processing algorithms – 
i.e., computationally heavy tasks operating on large 
files of images – which in turn place significant 
requirements on storage space, CPU power and/or 
network bandwidth on all participating hospitals, 
unless appropriate sharing of computing resources is 
arranged. Realising such a geographically distributed 
database therefore necessitates a grid infrastructure, 
and the construction of a prototype model which 
would push emerging grid technology to its limits. 
The MammoGrid project was carried out 
between mid 2002 and the end of 2005 and involved 
hospitals and medical imaging experts and academics 
in the UK, Italy and Switzerland with experience of 
implementing grid-based database solutions.  A key 
deliverable of the project was a prototype software 
infrastructure based on an open-source grid 
‘middleware’ (i.e. software that enables an underlying 
grid infrastructure to host domain applications) and a 
service-oriented database management system that is 
capable of managing federated mammogram 
databases distributed across Europe.  The proposed 
solution was a medical information infrastructure 
delivered on a service-based, grid-aware framework, 
encompassing geographical regions of varying 
clinical protocols and diagnostic procedures, as well 
as lifestyles and dietary patterns.  The prototype 
allows, among other things, mammogram data 
mining, diverse and complex epidemiological studies, 
statistical and (CADe) analyses, and the deployment 
of versions of the image standardization software. It 
was the intention of MammoGrid to get rapid 
feedback from a real clinical community about the 
use of such a simple grid platform to inform the next 
generation of grid projects in healthcare. 
The clinical work packages encompassed in 
MammoGrid prototypes address three selected 
clinical problems: 
1. Quality control: the effect on clinical 
mammography of image variability due to 
differences in acquisition parameters and 
processing algorithms; 
2. Epidemiological studies: the effects of population 
variability, regional differences such as diet or 
body habitus and the relationship to 
mammographic density (a potential biomarker of 
breast cancer) which may be affected by such 
factors; 
3. Support for radiologists, in the form of tele-
collaboration, second opinion, training and quality 
control of images. 
Other initiatives against which MammoGrid may 
be compared include: the eDiamond [4] project in the 
UK, and the NDMA [5] project in the US.  The 
MammoGrid approach shares many similarities with 
these projects, but in the case of the NDMA project 
its database is implemented in IBM’s DB2 on a single 
server. The MammoGrid project federates multiple 
(potentially heterogeneous) databases as its data 
store(s).  The Italian INFN project GP-CALMA  [6] 
has focused on a grid implementation of tumour 
detection algorithms to provide clinicians with a 
working mammogram examination tool. MammoGrid 
uses aspects of the CALMA project in its computer-
aided detection of microcalcifications. 
More recent grid-based research includes the 
BIRN [7] project in the US, which is enabling large-
scale collaborations in biomedical science by utilizing 
the capabilities of emerging grid technologies.  BIRN 
provides federated medical data, which enables a 
software ‘fabric’ for seamless and secure federation 
of data across the network and facilitates the 
collaborative use of domain tools and flexible 
processing/analysis frameworks for the study of 
Alzheimer’s disease.  The INFOGENMED initiative 
[8] has given the lead to projects in moving from 
genomic information to individualized healthcare 
using data distributed across Europe.   
From the outset, the MammoGrid project posted 
its objectives in terms of the promised radiological 
and epidemiological applications, but not in terms of 
new grid technology.  Its technology attitude has 
largely been one of re-use, not invention or 
development; only where required functionality was 
missing was there a need to implement new grid 
services. An information infrastructure to integrate 
multiple mammogram databases is clearly needed to 
enable clinicians to develop new common, 
collaborative and co-operative approaches to the 
analysis of mammographic images as is evident by 
the clinical evaluation that took place towards the end 
of the MammoGrid project. 
 
2. Results from MammoGrid 
The MammoGrid project has recently delivered 
its final proof-of-concept prototype enabling 
clinicians to store digitized mammograms along with 
appropriately anonymized patient metadata; the 
prototype provides controlled access to mammograms 
both locally and remotely stored. A typical database 
comprising several thousand mammograms has been 
created for user tests of clinicians’ queries. The 
prototype comprises: 
• a high-quality clinician visualization workstation 
(used for data acquisition and inspection); 
• an imaging standard-compliant interface to a set 
of medical services (annotation, security, image 
analysis, data storage and querying services) 
residing on a so-called 'Grid-box'; and 
• secure access to a network of other Grid-boxes 
connected through Grids middleware. 
To allow evaluation of the final prototype at the 
clinical sites, a MammoGrid Virtual Organization 
(MGVO) was established and deployed (see figure 1). 
The MGVO is composed of three mammography 
centres – Addenbrookes Hospital, Udine Hospital, 
and Oxford University. These centres are autonomous 
and independent of each other with respect to their 
local data management and ownership. The 
Addenbrookes and Udine hospitals have locally 
managed databases of mammograms, with several 
thousand cases between them. As part of the MGVO, 
registered clinicians have access to (suitably 
anonymized) mammograms, results, diagnosis and 
imaging software from other centres. Access is 
coordinated by the MGVO central node at CERN. 
The adopted grid implementation is the ALICE 
Environment (AliEn) [9] component of the EGEE-
gLite middleware [10], the grid middleware of the 
EU-funded EGEE project [11]. The service-oriented 
approach adopted in MammoGrid permits the 
interconnection of communicating entities, called 
services, which provide capabilities through exchange 
of messages. The services are ‘orchestrated’ in terms 
of service interactions: how services are discovered, 
how they are invoked, what may be invoked, the 
sequence of service invocations, and who can execute 
them. 
Evaluation of the MammoGrid prototype took 
place using the MGVO over a set of clinical work 
packages performed by senior radiologists at the two 
hospitals. The MammoGrid Virtual Organization 
encompassed data accessible to the radiologists at the 
hospitals, as well as at Oxford University and CERN. 
The evaluation comprised the qualitative and, where 
possible, quantitative assessment of the use-cases 
captured during the requirements analysis phase of 
the project. 
 
 
 
 
Figure 1: The MammoGrid Virtual Organisation 
 
 
During the evaluation the radiologists have been 
able to view raw image data from each others’ 
hospitals and have been able to second read grid-
resident mammograms and to separately annotate the 
images for combined diagnosis. This has 
demonstrated the viability of distributed image 
analysis using the grid and shown considerable 
promise for future health-based grid applications. 
Despite the anticipated performance limitations that 
existing grid software imposes on the system usage, 
the clinicians have been able to discover new ways to 
collaborate using the virtual organization. These 
include the ability to perform queries over a virtual 
repository spanning data held in Addenbrookes and 
Udine.  
Following the ‘Perform Radiological Analysis’ 
use-case scenario, identified during the project’s 
requirements analysis phase, clinicians define their 
mammogram analysis in terms of queries they wish to 
be resolved across the federation of data repositories. 
Queries can be categorized into simple queries 
(mainly against associated data stored in the database 
as simple attributes) and complex queries which 
require derived data to be interrogated or an 
algorithm to be executed on a (sub-)set of distributed 
images. The important aspect is that image and data 
distribution are transparent for radiologists so queries 
are formulated and executed as if these images were 
locally resident.  Queries are executed at the location 
where the relevant data resides, i.e. sub-queries are 
moved to the data, rather than large quantities of data 
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being moved to the clinician, which can be 
prohibitively expensive given the quantities of data. 
Clinicians continue in the process of scanning 
and annotating cases contributing to several ongoing 
medical studies. These include (1) Cancers versus 
control study:  breast density study using the standard 
mammogram form (SMFTM) standard [12] (2) 
Dose/density study: exploring the relationship 
between mammographic density, age, breast size and 
radiation dose (3) CADe and validation of SMF in 
association with CADe. These studies continue to 
show how health professionals can work together 
without co-locating. Importantly the collaborative 
approach pursued in MammoGrid has already 
identified new ways in which clinicians can work 
together using a common grid-based repository which 
were hitherto not possible. For example, the use of 
the SMF algorithm on data supported by MammoGrid 
and accessible to radiologists in Cambridge and 
Udine for the purposes of joint mammogram analysis 
has directly led to results recently submitted to 
European Radiology [13].   
In summary, during the final months of the 
project the clinicians have been evaluating the 
MammoGrid prototype across two applications. First, 
the project has facilitated the use of the SMF software 
to measure breast density.  The clinical project, 
designed jointly by Cambridge and Udine, explored 
the relationship between mammographic density, age, 
breast size, and radiation dose.  In this project, breast 
density has been measured by SMF and compared 
with standard methods of visual assessment.  Heights, 
weights, and mass indicators are used in an 
international comparison, although a richer dataset 
would be needed to study effects of lifestyle factors 
such as diet or HRT use between the two national 
populations. Second, the University of Udine led a 
project to validate the use of SMF in association with 
CADe from the CALMA project.  Cancers and 
benign lesions have been supplied from the clinical 
services of Udine and Cambridge to provide the 
benchmarking and the set of test cases.  Cancer cases 
will include women whose unaffected breast will 
serve the density study to provide cases for the CADe 
analysis from the affected side mammogram.  
MammoGrid has demonstrated that these new forms 
of clinical collaboration can be supported using the 
grid [14]. 
This is expected to result in improved research 
quality as well as improved citizen access to the latest 
healthcare technologies. 
3. Technology Transfer 
By using grid computing, the MammoGrid 
system allows hospitals, healthcare workers and 
researchers to share data and resources, while 
benefiting from an augmented overall infrastructure. 
It supports effective co-working, such as obtaining 
second opinion, provides the means for powerful 
comparative analysis of mammograms and opens the 
door to novel, broad-based statistical analysis of the 
incidence and forms of breast cancer. Through the 
MammoGrid project, partners have developed a 
strong collaboration between radiologists active in 
breast cancer research and academic computer 
scientists with expertise in the applications of grid 
computing. The success of the project has led to 
interest from outside companies and hospitals, with 
one Spanish company, Maat GKnowledge, looking to 
deploy a commercial variant of the system in three 
hospitals of the Extremadura region in Spain. Maat 
GKnowledge aims to provide doctors with the ability 
to verify test results, to obtain a second opinion and 
to make use of the clinical experience acquired by the 
hospitals involved in the project. They then aim to 
scale the system up and to expand it to other areas of 
Spain and then Europe. With the inclusion of new 
hospitals, the database will increase in coverage and 
the knowledge will increase in relevance and 
accuracy, enabling larger and more refined 
epidemiological studies. Therefore, clinicians will be 
provided with a significant data set to serve better 
their investigations in the domain of cancer 
prevention, prediction and diagnoses. This will result 
in improved research quality as well as improved 
citizen access to the latest healthcare technologies. 
The MammoGrid system prototype has been at 
the leading edge of the healthgrid revolution and 
implements for the first time such a solution for 
mammogram acquisition and manipulation. The 
resulting application has reached a high level of 
complexity which now requires continued partnership 
between academics, clinicians and industry to provide 
the necessary technology transfer and to enable real 
commercialisation. In this context, the MammoGrid 
Technology Transfer and Innovation eXchange 
(MaTTrIX) project has been proposed as an ideal 
means to transfer the project knowledge and expertise 
from the research to the commercial domain, to make 
its innovation available to the company Maat 
GKnowledge in Spain, to carry forward research 
findings to radiological practice and to reinforce 
existing partnerships between networks of clinicians 
and technologists. To achieve these objectives, the 
intention is to introduce a service which exploits the 
findings of the MammoGrid project in practice, while 
the researchers also learn from the application of their 
ideas in a real environment. This will create a two-
way innovation flow between the academic and 
commercial worlds, building on existing synergies 
and collaborations, and improving the overall 
viability and commercialisation of the MammoGrid 
system software. 
To this end, the host organisation Maat 
GKnowledge, the University of the West of England, 
Bristol, CIEMAT (Centro de Investigaciones 
Energéticas, Medioambientales y Tecnológicas), 
Spain, and CERN together with clinical partners at 
the University hospitals in Cambridge and Udine and 
at the Hospitals Infanta Cristina, Merida and San 
Benito in Extremadura are initiating a transfer of 
knowledge, research competences and technologies to 
enable the company to take over future development 
of the MammoGrid system. This will enable the 
training of existing Maat GKnowledge staff in 
MammoGrid technologies and the acquisition of the 
technology and know-how for commercialisation. 
This transfer would constitute the mechanism for the 
creation and development of a durable technology 
and knowledge transfer partnership. 
The MaTTrIX technology transfer approach 
relies on two main cornerstones: 
• to promote the mobility of key experienced 
researchers, to absorb, expand and disseminate 
the knowledge for the MammoGrid system to 
evolve gradually into a commercial offering, 
making it available for healthcare across the 
European Research Area (ERA) as a viable and 
clinically assessed solution; and 
• to create and to develop a strategic and durable 
partnership between new hospitals and partners 
of the MammoGrid project, providing a sound 
foundation for a network of excellence in 
European research. 
Having paved the way for potential knowledge 
discovery in the understanding of breast cancer, the 
MammoGrid project has also determined new 
important research paths for better cancer prediction 
and diagnosis. The use of a standard format for 
mammogram images (SMF) and its outcome in the 
epidemiological investigations, has demonstrated the 
relevance of new grid-based clinical studies, which 
may lead to major advances in cancer prediction. In 
addition, while most computer-aided detection 
(CADe) systems process raw and noisy data at the 
price of accuracy and quality, the implemented 
solutions in MammoGrid have indicated the valuable 
joint use of SMF and CADe tools to improve 
automated cancer diagnosis. Considering the IT 
contribution in MammoGrid, the distributed 
technologies used in the project combined with the 
recent clinical feedback, obtained from the 
assessment of the proof-of-concept prototype, have 
highlighted the importance of offering a collaborative 
platform for healthcare. Not only would such a 
solution demonstrate the benefits of clinical second 
opinion, but it would also help in reducing the 
information infrastructure costs by enabling 
heterogeneous and scalable resource sharing, 
resulting in an improved system access even to less 
favoured regions and countries in Europe. 
Emphasising this last point the Hospitals of 
Infanta Cristina, Merida and San Benito in 
Extremadura in Spain, will obtain access to the 
MammoGrid system and expertise at a reduced cost, 
the infrastructure being already in place. While 
accessing the latest technologies and software, these 
hospitals will share and enrich their clinical 
experience by interacting with other trained clinicians 
from the university hospitals in Cambridge and Udine 
to obtain expertise in the use of SMF and CADe. 
Academic computer scientists will continue to 
analyse the ways in which new functionality is 
exploited by radiologists in their protocols and 
workflows, maintaining the design of the system 
under review.  This new partnership will result in 
improved processes locally and also in refined 
clinical knowledge being made available in a Europe-
wide production reference database, enabling new 
clinical studies in the spirit of improving cancer 
prediction and detection. It is hoped that this 
collaboration will provide a significant exemplar for 
the European Research Area. 
The MammoGrid project has deployed its first 
prototype and has performed the first phase of in-
house tests, in which a representative set of 
mammograms have been tested between sites in the 
UK, Switzerland and Italy. In the next phase of 
testing, clinicians will be closely involved in 
performing tests and their feedback will be 
reflectively utilised in improving the applicability and 
performance of the system. In its first two years, the 
MammoGrid project has faced interesting challenges 
originating from the interplay between medical and 
computer sciences, and has witnessed the excitement 
of the user community whose expectations from a 
new paradigm are understandably high. As the 
MammoGrid project moves into its final 
implementation and testing phase, further challenges 
are anticipated. In conclusion, this paper has outlined 
the MammoGrid application’s deployment strategy 
and experiences.  Also, it outlines the strategy being 
adopted for migration to the new lightweight 
middleware called gLite.  
Whereas the MammoGrid system was meant to 
be grid middleware independent in its latest releases, 
the MammoGrid Plus software will be based on 
AliEn combined with Maat’s proprietary “G” 
database management system. Indeed, MammoGrid 
Plus being a commercial product, the objective is not 
to make it as generic as possible to other middleware, 
but rather to acquire the expertise on a particular one. 
In a commercial context, this will highly facilitate the 
maintenance and issues faced in the usage of the 
system. Also, without an established standard for grid 
middleware, it is not commercially viable to open the 
system to several different middleware prototypes.  
However, it should be noted that the philosophy 
behind the integration of the “G” database 
management system as a junction layer between 
domain services and grid services will provide the 
necessary abstraction in case of a middleware 
replacement. AliEn functionalities will be accessible 
as if querying/populating a regular database, the latter 
acting directly on the middleware data. 
Despite this fact, the MammoGrid Plus software 
will comply with the main design principles of 
MammoGrid in addressing the improvement (and 
enrichment if required) of the metadata database 
infrastructure. To do so, it will provide a proper 
distributed DMS layer following the metadata 
schemas designed in MammoGrid. 
Based on Maat’s recent advances in 
collaboration with CERN, the grid middleware used 
for the MammoGrid Plus product will be a modified 
AliEn lightweight grid middleware featured with the 
“G” DBMS as the basis of its File Catalogue.  
Aspects of the File Catalogue in AliEn have been 
well suited to a research environment, but are not 
appropriate in a commercial context where the 
emphasis is mainly on performance. 
By leveraging middleware performance and 
scalability, the MammoGrid Plus product will be 
ready for intensive use in production environments. In 
addition, using the “G” system, the overall security 
and privacy of the software will be improved at the 
functionality level. Indeed, one of the weaknesses of 
AliEn is its poor capability of representing user’s 
authorization/roles. Using AliEn, it is not possible to 
obtain a fine-grained role definition for the users of 
the system, the middleware only distinguishing 
between normal users and admin users. The “G” 
platform, allows for the definition of a complete set 
of roles and authorization accesses.  Thus, in the 
MammoGrid Plus software it will be possible to 
extend the scope of the system by distinguishing 
different clinicians’ roles in a given virtual 
organization, opening the room for new 
functionalities where each user will obtain a 
customized access to the software offer. 
4. Conclusions 
MammoGrid is one of several current projects 
that aim to harness recent technological advances to 
achieve the goal of complex data storage in support 
of medical applications.  The approaches vary widely, 
but at least two projects, e-Diamond in the UK and 
MammoGrid in Europe, have adopted the grid as 
their platform of choice for the delivery of improved 
quality control, more accurate diagnosis and 
statistically significant epidemiology.  Since breast 
screening in the UK and in Italy has been based on 
film, mammograms have had to be digitised for use in 
both e-Diamond and MammoGrid.  By contrast, the 
NDMA project in the United States has opted for 
centralised storage of direct digital mammograms.  
The next step for MammoGrid, its application in the 
Spanish region of Extremadura, will be based on both 
film and direct digital mammography. 
The central feature of the MammoGrid project is 
a geographically distributed, grid-based database of 
standardised images and associated patient data.  The 
novelty of the MammoGrid approach lies in the 
application of grid technology and in the provision of 
data and tools, which enable radiologists to compare 
new mammograms with existing ones on the grid 
database, allowing them to make comparative 
diagnoses as well as judgements about quality.  In the 
longer term, as the potential of the database is to be 
populated with provenance-controlled, reliable data 
from across Europe, with the prospect of statistically 
robust epidemiology that allows analysis of ‘lifestyle’ 
factors, including, e.g., diet, exercise and exogenous 
hormone use.  And, hence the grid would also be 
suitable for storing genetic or pathological image 
information. 
The project has attracted attention as a paradigm 
for grid-based radiology and imaging applications.  
While it has not yet solved all problems, the project 
has established an approach and a prototype platform 
sharing medical data, especially images, across a grid.  
In loose collaboration with a number of other 
European medical grid projects, it is addressing the 
issues of informed consent and ethical approval, data 
protection, compliance with institutional, national and 
European regulations, and security. In conclusion, the 
MammoGrid project may be considered as a major 
advance in bridging the gap between the grid as an 
advanced distributing computing infrastructure and 
the medical domain and therefore should enable 
further grid-based projects to benefit from both its 
main lessons and its results. 
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